Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Abramson

Showing results (171-180 of 179) with videos related to

Pageof 18
Sort By:
You have reached the last page of results.This site can display upto 179 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 19, 2023
Circulating tumor DNA association with residual cancer burden after neoadjuvant chemotherapy in triple-negative breast cancer in TBCRC 030H A Parsons, T Blewett, X Chu, et al.
Tomography (Ann Arbor, Mich.)|March 12, 2019
The Impact of Arterial Input Function Determination Variations on Prostate Dynamic Contrast-Enhanced Magnetic Resonance Imaging Pharmacokinetic Modeling: A Multicenter Data Analysis Challenge, Part IIWei Huang, Yiyi Chen, Andriy Fedorov, et al.
Medrxiv : the Preprint Server for Health Sciences|March 22, 2023
Circulating tumor DNA association with residual cancer burden after neoadjuvant chemotherapy in triple-negative breast cancer in TBCRC 030Heather A Parsons, Timothy Blewett, Xiangying Chu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 23, 2020
Changes in Peripheral and Local Tumor Immunity after Neoadjuvant Chemotherapy Reshape Clinical Outcomes in Patients with Breast CancerMargaret L Axelrod, Mellissa J Nixon, Paula I Gonzalez-Ericsson, et al.
JCO Oncology Practice|July 19, 2024
Subcutaneous vs Intravenous Trastuzumab/Pertuzumab: A Time and Motion Substudy of a Phase II Trial of Adjuvant Trastuzumab/Pertuzumab for Stage I HER2+ Breast Cancer (ADEPT trial)Adrienne G Waks, Emily L Chen, Noah Graham, et al.
Cancer Research Communications|April 30, 2024
Epithelial Expressed B7-H4 Drives Differential Immunotherapy Response in Murine and Human Breast CancerElizabeth C Wescott, Xiaopeng Sun, Paula Gonzalez-Ericsson, et al.
Breast Cancer Research and Treatment|August 17, 2023
Identifying homologous recombination deficiency in breast cancer: genomic instability score distributions differ among breast cancer subtypesLauren Lenz, Chris Neff, Cara Solimeno, et al.
European Radiology|August 22, 2023
Effects of a comprehensive brain computed tomography deep learning model on radiologist detection accuracyQuinlan D Buchlak, Cyril H M Tang, Jarrel C Y Seah, et al.
Breast Cancer Research and Treatment|May 8, 2020
Clinical evaluation of germline polymorphisms associated with capecitabine toxicity in breast cancer: TBCRC-015Peter H O'Donnell, Vassily Trubetskoy, Ashley Nurhussein-Patterson, et al.
Pageof 18

Showing results (171-180 of 179) with videos related to

Sort By:
Pageof 18
You have reached the last page of results.This site can display upto 179 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 19, 2023
Circulating tumor DNA association with residual cancer burden after neoadjuvant chemotherapy in triple-negative breast cancer in TBCRC 030H A Parsons, T Blewett, X Chu, et al.
Tomography (Ann Arbor, Mich.)|March 12, 2019
The Impact of Arterial Input Function Determination Variations on Prostate Dynamic Contrast-Enhanced Magnetic Resonance Imaging Pharmacokinetic Modeling: A Multicenter Data Analysis Challenge, Part IIWei Huang, Yiyi Chen, Andriy Fedorov, et al.
Medrxiv : the Preprint Server for Health Sciences|March 22, 2023
Circulating tumor DNA association with residual cancer burden after neoadjuvant chemotherapy in triple-negative breast cancer in TBCRC 030Heather A Parsons, Timothy Blewett, Xiangying Chu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 23, 2020
Changes in Peripheral and Local Tumor Immunity after Neoadjuvant Chemotherapy Reshape Clinical Outcomes in Patients with Breast CancerMargaret L Axelrod, Mellissa J Nixon, Paula I Gonzalez-Ericsson, et al.
JCO Oncology Practice|July 19, 2024
Subcutaneous vs Intravenous Trastuzumab/Pertuzumab: A Time and Motion Substudy of a Phase II Trial of Adjuvant Trastuzumab/Pertuzumab for Stage I HER2+ Breast Cancer (ADEPT trial)Adrienne G Waks, Emily L Chen, Noah Graham, et al.
Cancer Research Communications|April 30, 2024
Epithelial Expressed B7-H4 Drives Differential Immunotherapy Response in Murine and Human Breast CancerElizabeth C Wescott, Xiaopeng Sun, Paula Gonzalez-Ericsson, et al.
Breast Cancer Research and Treatment|August 17, 2023
Identifying homologous recombination deficiency in breast cancer: genomic instability score distributions differ among breast cancer subtypesLauren Lenz, Chris Neff, Cara Solimeno, et al.
European Radiology|August 22, 2023
Effects of a comprehensive brain computed tomography deep learning model on radiologist detection accuracyQuinlan D Buchlak, Cyril H M Tang, Jarrel C Y Seah, et al.
Breast Cancer Research and Treatment|May 8, 2020
Clinical evaluation of germline polymorphisms associated with capecitabine toxicity in breast cancer: TBCRC-015Peter H O'Donnell, Vassily Trubetskoy, Ashley Nurhussein-Patterson, et al.
Pageof 18